Viemed Healthcare Announces Share Repurchase Program Up to 5% of Outstanding Shares.
ByAinvest
Monday, Jun 9, 2025 8:21 am ET1min read
VMD--
Viemed plans to repurchase shares through various means, including open market purchases and block purchases, in accordance with applicable securities laws. Daily purchases will be limited to 25% of the average daily volume for the four calendar weeks preceding the date of purchase, except for block purchases [1].
Casey Hoyt, the Chief Executive Officer of Viemed, highlighted the company's strong financial performance and commitment to shareholder value. He noted that the company's recent first quarter 2025 results and the increases in its 2025 guidance range midpoints demonstrate its robust execution and underlying fundamentals. Additionally, Viemed's track record of disciplined capital allocation, including the acquisition of Lehan's Medical, underscores its commitment to executing on its capital allocation strategies [1].
With no net debt and full availability on its $55 million credit facility, Viemed has ample liquidity to improve shareholder value through this share repurchase program while also funding its organic and inorganic growth initiatives [1].
The price paid for the common shares will be the market price at the time of purchase, plus applicable brokerage fees, or such other prices as may be permitted by applicable securities laws. The exact number of shares repurchased under the program cannot be guaranteed, and the company may discontinue its purchases at any time, subject to compliance with applicable securities laws. The common shares purchased by the company will be cancelled [1].
References:
[1] https://www.morningstar.com/news/globe-newswire/9464872/viemed-healthcare-announces-share-repurchase-program
XYZ--
Viemed Healthcare, a national leader in in-home post-acute respiratory care, has announced a share repurchase program. The program will run through June 2026 and allows the company to purchase up to 1,976,441 common shares, or approximately 5% of the total issued and outstanding shares. Viemed plans to repurchase shares through open market purchases, block purchases, or other means in accordance with applicable securities laws.
Viemed Healthcare, Inc., a leading provider of in-home post-acute respiratory care, has authorized a share repurchase program that will run through June 2026. The program, announced on June 9, 2025, allows the company to purchase up to 1,976,441 common shares, which represents approximately 5% of the total issued and outstanding shares as of March 31, 2025 [1].Viemed plans to repurchase shares through various means, including open market purchases and block purchases, in accordance with applicable securities laws. Daily purchases will be limited to 25% of the average daily volume for the four calendar weeks preceding the date of purchase, except for block purchases [1].
Casey Hoyt, the Chief Executive Officer of Viemed, highlighted the company's strong financial performance and commitment to shareholder value. He noted that the company's recent first quarter 2025 results and the increases in its 2025 guidance range midpoints demonstrate its robust execution and underlying fundamentals. Additionally, Viemed's track record of disciplined capital allocation, including the acquisition of Lehan's Medical, underscores its commitment to executing on its capital allocation strategies [1].
With no net debt and full availability on its $55 million credit facility, Viemed has ample liquidity to improve shareholder value through this share repurchase program while also funding its organic and inorganic growth initiatives [1].
The price paid for the common shares will be the market price at the time of purchase, plus applicable brokerage fees, or such other prices as may be permitted by applicable securities laws. The exact number of shares repurchased under the program cannot be guaranteed, and the company may discontinue its purchases at any time, subject to compliance with applicable securities laws. The common shares purchased by the company will be cancelled [1].
References:
[1] https://www.morningstar.com/news/globe-newswire/9464872/viemed-healthcare-announces-share-repurchase-program

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet